SCHEMBL5652611

SCHEMBL5652611

O=C1CCC(N2Cc3ccccc3NC2=O)C(=O)N1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 17/20 0.67
DDB1 Q16531 5/20 0.53
IKZF3 Q9UKT9 2/20 0.52
ALDH1A1 P00352 1/20 0.52
CHRM2 P08172 1/20 0.52
OPRM1 P35372 1/20 0.52
CYP1A2 P05177 1/20 0.52
TSHR P16473 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
BRD4 O60885 2/20 0.48
TNF P01375 1/20 0.48
IL1B P01584 1/20 0.48
IKZF1 Q13422 1/20 0.48
CSNK1A1 P48729 1/20 0.47
CREBBP Q92793 1/20 0.46
NPC1 O15118 1/20 0.46
MAPK13 O15264 1/20 0.46
MAPK12 P53778 1/20 0.46
MAPK11 Q15759 1/20 0.46
MAPK14 Q16539 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398140 0.87 BRD4 (0.50) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL27097754 0.80 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22564887 0.80 CRBN (0.67) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL476917 0.80 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL19556665 0.80 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL19556664 0.80 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29346462 0.79 KDM4E (0.46) CRBNALDH1A1TSHRBRD4CREBBP
SCHEMBL20128634 0.78 CRBN (0.76) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL6178113 0.77 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL6180704 0.77 CRBN (1.00) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155967-A1 Process for producing piperidine-2,6 diones heterocyclically substituted in the 3-position GRUENENTHAL GMBH (DE) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155967-A1 Process for producing piperidine-2,6 diones heterocyclically substituted in the 3-position OGDH, GLUL, PGD CRBN 2485/4885DDB1 4077/4885IKZF3 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.